Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.
2.

Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.

Wagner J, Suessmair C, Pfister HW.

J Neurol. 2009 Jul;256(7):1182-3. doi: 10.1007/s00415-009-5078-6. Epub 2009 Mar 1. No abstract available.

PMID:
19252767
3.

Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.

Kahri AJ, Valkonen MM, Vuoristo MK, Pentikäinen PJ.

Ann Pharmacother. 2004 Apr;38(4):719. Epub 2004 Feb 13. No abstract available.

PMID:
14966253
4.

Rhabdomyolysis in association with simvastatin and amiodarone.

Roten L, Schoenenberger RA, Krähenbühl S, Schlienger RG.

Ann Pharmacother. 2004 Jun;38(6):978-81. Epub 2004 Apr 6.

PMID:
15069169
5.

Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin.

Page SR, Yee KC.

Intern Med J. 2014 Jul;44(7):690-3. doi: 10.1111/imj.12464.

PMID:
25041770
6.

Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.

Lee AJ, Maddix DS.

Ann Pharmacother. 2001 Jan;35(1):26-31. Review.

PMID:
11197581
7.

Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.

Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX.

Ann Intern Med. 2013 Jun 18;158(12):869-76. doi: 10.7326/0003-4819-158-12-201306180-00004.

PMID:
23778904
8.

Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin.

Gruer PJ, Vega JM, Mercuri MF, Dobrinska MR, Tobert JA.

Am J Cardiol. 1999 Oct 1;84(7):811-5.

PMID:
10513779
10.

Potential drug interaction between simvastatin and danazol causing rhabdomyolysis.

Andreou ER, Ledger S.

Can J Clin Pharmacol. 2003 Winter;10(4):172-4.

PMID:
14712320
11.

Statin-induced rhabdomyolysis.

Schreiber DH, Anderson TR.

J Emerg Med. 2006 Aug;31(2):177-80. Review.

PMID:
17044581
12.

Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.

Schmidt GA, Hoehns JD, Purcell JL, Friedman RL, Elhawi Y.

J Am Board Fam Med. 2007 Jul-Aug;20(4):411-6.

13.

HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions.

Huynh T, Cordato D, Yang F, Choy T, Johnstone K, Bagnall F, Hitchens N, Dunn R.

Intern Med J. 2002 Sep-Oct;32(9-10):486-90.

PMID:
12380704
14.

Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin.

Mogyorósi A, Bradley B, Showalter A, Schubert ML.

J Intern Med. 1999 Dec;246(6):599-602.

15.

Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.

Tal A, Rajeshawari M, Isley W.

South Med J. 1997 May;90(5):546-7.

PMID:
9160078
16.

[Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity].

Meier C, Stey C, Brack T, Maggiorini M, Risti B, Krähenbühl S.

Schweiz Med Wochenschr. 1995 Jul 11;125(27-28):1342-6. German.

PMID:
7624744
17.

Presumed interaction of fusidic acid with simvastatin.

Burtenshaw AJ, Sellors G, Downing R.

Anaesthesia. 2008 Jun;63(6):656-8. doi: 10.1111/j.1365-2044.2007.05434.x.

18.

Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.

McKinnell J, Tayek JA.

J Clin Rheumatol. 2009 Sep;15(6):303-5. doi: 10.1097/RHU.0b013e3181bbbcd7.

PMID:
19734738
19.

[Rhabdomyolysis and cholestatic hepatitis under treatment with simvastatin and chlorzoxazone].

Bielecki JW, Schraner C, Briner V, Kuhn M.

Schweiz Med Wochenschr. 1999 Apr 3;129(13):514-8. German.

PMID:
10322565
20.

Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine.

Justiniano M, Dold S, Espinoza LR.

J Clin Rheumatol. 2007 Oct;13(5):266-8.

PMID:
17921794

Supplemental Content

Support Center